These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Do TNF-blockers reduce or induce uveitis? Cobo-Ibáñez T; del Carmen Ordóñez M; Muñoz-Fernández S; Madero-Prado R; Martín-Mola E Rheumatology (Oxford); 2008 May; 47(5):731-2. PubMed ID: 18346974 [No Abstract] [Full Text] [Related]
4. Uveitis and tumour necrosis factor blockade in ankylosing spondylitis. Coates LC; McGonagle DG; Bennett AN; Emery P; Marzo-Ortega H Ann Rheum Dis; 2008 May; 67(5):729-30. PubMed ID: 18408116 [No Abstract] [Full Text] [Related]
5. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents. Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227 [No Abstract] [Full Text] [Related]
6. Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study. Gisondi P; Cotena C; Tessari G; Girolomoni G J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):341-4. PubMed ID: 18005022 [TBL] [Abstract][Full Text] [Related]
7. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results. Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981 [TBL] [Abstract][Full Text] [Related]
8. Effective co-administration of infliximab and etanercept following the failure of sequential anti-TNF agents in a patient with HLA-B27-associated arthropathy. Sheehy C; Murphy E; Barry M Rheumatology (Oxford); 2006 Oct; 45(10):1314-5. PubMed ID: 16837474 [No Abstract] [Full Text] [Related]
9. Increase in plasma levels of adiponectin after administration of anti-tumor necrosis factor agents in patients with rheumatoid arthritis. Nagashima T; Okubo-Fornbacher H; Aoki Y; Kamata Y; Kimura H; Kamimura T; Nara H; Iwamoto M; Yoshio T; Okazaki H; Minota S J Rheumatol; 2008 May; 35(5):936-8. PubMed ID: 18464318 [No Abstract] [Full Text] [Related]
10. Anti-tumour necrosis factor agents and lipid profile: a class effect? Garcês SP; Parreira Santos MJ; Vinagre FM; Roque RM; da Silva JA Ann Rheum Dis; 2008 Jun; 67(6):895-6. PubMed ID: 18474660 [No Abstract] [Full Text] [Related]